Kate Shaw comments on the latest news about AstraZeneca and Merck's decision to hold planned investments in the UK ...

Under the agreement, CSL will fully fund VarmX’s phase 3 trial of its lead candidate, VMX-C001, and retains an exclusive ...

Lucid Group announces the evolution of its consulting division, Lucid Strategy Consulting, setting a new standard for ...

Cell and gene therapy (CGT) is a unique treatment that uses cells and genetic material to treat and cure diseases.

Cell and gene therapies (CGT) provide transformative treatment that can treat conditions that were previously considered ...

This article concludes our three-part series on preparing cell and gene therapies (CGTs) for successful launch and long-term ...

Amgen and Kyowa Kirin have announced preliminary top-line results from the ASCEND study evaluating rocatinlimab, an ...

Tom Smith, Strategic Director, Cell and Gene Therapies, Uniphar, discusses the essential elements biotechs need for ...

The inaugural PMi Awards took place on 11 September at The Brewery, London. After 15 years as the PM Society Digital Awards, ...

Johnson & Johnson has submitted an application for European Medicines Agency (EMA) approval of icotrokinra to treat adults ...

Simulation has never been more vital in medicine than it is today. As increasing numbers of physicians turn to large language ...

Medscape Oncology is pleased to announce the launch of a groundbreaking new learning space designed to provide education ...